Implementation and evaluation of medicine and therapeutic information service by clinical pharmacists in oncology care setting

Abstract

Background

This study was conducted to explore the role of clinical pharmacists in providing medicine and therapeutic information service in oncology care setting.

Methods

It was a prospective study conducted for a period of three years after implementation of medicine and therapeutic information service as an integral part of oncology pharmacy services. The medicine and therapeutic information queries were received during ward rounds, at ambulatory care and via telephone by clinical pharmacists. All the medicine and therapeutic information requests were reviewed and answered to the concerned requester(s). Answered medicine and therapeutic information requests were electronically documented in the hospital drug information database and analyzed further.

Results

A total of 484 medicine and therapeutic information requests were received by clinical pharmacists during period of August 2013 to June 2016. Majority of medicine and therapeutic information queries were requested by radiation oncologists (27.2%) followed by medical oncologists (26.4%), general physicians (14.04%), resident medical officers (11.7%), ambulatory care nurses (8.6%), in-patient nurses (5.1%) and patients and care takers (6.6%). Majority of the medicine and therapeutic information queries were asked for the purpose of improving patient care (48.3%) followed by to update knowledge (30.9%) and training sessions to nurses (6.6%). The most common categories of medicine and therapeutic information were adverse drug reactions and its management (21.4%) followed by dosage adjustments of chemotherapy and biologicals (15.5%), supportive care related (14.6%), contraindications (14%), drug–drug interactions (11.9%), management of co-morbidities (7.8%), chemotherapy selection in special populations (4.5%).

Conclusion

The provision of medicine and therapeutic information was found to be useful in providing medicine information to improve patient care and to update knowledge of health care professionals at the study hospital.

Keywords

Drug information oncology care oncology pharmacy services clinical pharmacists in cancer care medicine and therapeutic information

Get full access to this article

View all access options for this article.

References

DeSantis

Lin

Mariotto

et al.

Cancer treatment and survivorship statistics, 2014. Cancer J Clin 2014; 64: 252–271.

Kaboli

Hoth

McClimon

et al.

Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006; 166: 955–964.

Singhal

Raisch

Gupchup

. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999; 33: 1336–1355.

Crespo

Tyszka

. Evaluating the patient-perceived impact of clinical pharmacy services and proactive follow-up care in an ambulatory chemotherapy unit. J Oncol Pharm Pract 2017; 23: 243–248.

Hsieh

Chan

Kim

et al.

Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries. Support Care Cancer 2015; 23: 263–272.

Schnipper

Kirwin

Cotugno

et al.

Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006; 166: 565–571.

Ventafridda

Tamburini

Caraceni

et al.

A validation study of the WHO method for cancer pain relief. Cancer 1987; 59: 850–856.

Rosenberg

Koumis

Nathan

et al.

Current status of pharmacist-operated drug information centers in the United States. Am J Health System Pharm 2004; 61: 2023–2032.

Patel

Churi

Gurumurthy

et al.

Quality assurance of drug information service and drug therapy review provided by clinical pharmacists in an Indian teaching hospital. Ind J Pharm Pract 2015; 8: 117–117.

10.

Dubois

Singh

. From staff-mix to skill-mix and beyond: towards a systemic approach to health workforce management. Hum Res Health 2009; 7: 87–87.

11.

National cancer Institute 2016, www.cancer.gov/about-cancer/understanding/statistics (accessed 4 August 2017).

12.

Mazhar

Ansari

Rajput

. Clinical pharmacy in India: recent advances and perspective. Pharma Tutor 2015; 3: 31–36.

13.

Felton

van Londen

Marcum

. Medication adherence to oral cancer therapy: the promising role of the pharmacist. J Oncol Pharm Pract 2016; 22: 378–381.

14.

Pickard

Johnson

Farris

. The impact of pharmacist interventions on health-related quality of life. Ann Pharmacother 1999; 33: 1167–1172.

15.

Prescott

Dickens

Guerra

et al.

Fighting cancer together: development and implementation of shared medical appointments to standardize and improve chemotherapy education. Gynecol Oncol 2016; 140: 114–119.